The discovery of a serum antibody, termed aquaporin-4 antibody, directed against the aquaporin4 (AQP4) channel expressed at the CNS interfaces, has enhanced the understanding of NMOSD which is now considered an autonomous entity with distinctive pathophysiology, different from multiple sclerosis [1]. Here, AQP4 is linked to multiple sclerosis.